Fresenius Medical Care AG & Co. KGaA (FMS) is a Medical - Care Facilities company in the Healthcare sector, currently trading at $23.21. It has a SharesGrow Score of 68/100, indicating a above average investment profile with 3 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of FMS = $92.95 (+300.5% from the current price, the stock appears undervalued). Analyst consensus target is FMS = $28 (+20.6% upside).
Valuation: FMS trades at a trailing Price-to-Earnings (P/E) of 11.7 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 1.34.
Financials: revenue is $19.6B, +0.4%/yr average growth. Net income is $978M, growing at +21.2%/yr. Net profit margin is 5% (thin). Gross margin is 25.6% (-1.8 pp trend).
Balance sheet: total debt is $10.8B against $14.3B equity (Debt-to-Equity (D/E) ratio 0.76, moderate). Current ratio is 1.26 (adequate). Debt-to-assets is 34.8%. Total assets: $31.0B.
Analyst outlook: 5 / 18 analysts rate FMS as buy (28%) — mixed sentiment.
SharesGrow 7-Criteria breakdown: Value 83/100 (Pass), Growth 73/100 (Pass), Past 100/100 (Pass), Health 67/100 (Partial), Moat 59/100 (Partial), Future 46/100 (Partial), Income 45/100 (Partial).
